Carlotta Scarpa, Vincenzo Vindigni, Franco Bassetto. The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease. Ann Ital Chir [Internet]. 2020 Oct. 1 [cited 2025 May 18];9(September):1-3. Available from: https://annaliitalianidichirurgia.it/index.php/aic/article/view/606